ReviewCurrent oncology (Toronto, Ont.)2026

Trop2-Based Antibody-Drug Conjugates: Emerging Strategy and Progress in Triple-Negative Breast Cancer Therapy.

Tong Li et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.